EQS-News: Temedica and Roche extend successful partnership and celebrate milestones with digital patient companions
- 46
EQS-News: Temedica GmbH
/ Key word(s): Miscellaneous
PRESS RELEASE
Temedica and Roche extend successful partnership and celebrate milestones with digital patient companions
Munich, October 24, 2024 – Temedica, a leading health insights company based in Munich, and Roche announce the continuation and expansion of their successful long-standing partnership. Together, the two companies have already launched two digital patient companion apps. These include Retinora, developed for individuals with wet age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), and Brisa, a digital companion for people with multiple sclerosis. The Brisa collaboration is celebrating its fifth anniversary this year and will be extended due to its significant success. The “OcreKompass” project, a dedicated service for Ocrevus patients within Brisa, will also be expanded.
Since the initiative's launch, a five-figure number of patients have benefited from the apps. Numerous scientific studies have confirmed the value of using digital companions in improving patients' quality of life and medical care. The close collaboration between Temedica and Roche demonstrates how innovative partnerships can significantly enhance patient care.
Retinora and Brisa are built on Temedica's unique app platform technology, which is continuously developed to meet the specific needs of patients. The platform ensures scalability, compliance, and incorporates cutting-edge modules to support users.
Through integration with Temedica’s Real-World Evidence platform Permea, users of the digital companions regularly receive valuable insights generated from current research findings, and the aggregation and analysis of diverse data sources. Additionally, users can share their experiences for scientific research, actively contributing to the improvement of patient care. All data is handled in strict compliance with the General Data Protection Regulation (GDPR) and with the explicit consent of the users.
Prof. Dr. med. Tjalf Ziemssen, Head of the Center for Clinical Neurosciences and Professor of Clinical Neurosciences at the University Hospital of Dresden, emphasizes:
“Temedica and Roche’s digital companion apps are a crucial tool in empowering patients to manage their conditions and in utilizing Real-World Data to improve the standard of care. I am particularly familiar with the Brisa app and, based on the data, I can see the positive impact it has on patients' lives.”
Gloria Seibert, Founder and CEO of Temedica, and Maira Trauzettel, Integrated Strategy Lead Neuroimmunology at Roche Pharma AG, state: “The extension of our partnership sends a strong signal for growth and innovation in the digital health landscape. By combining technological expertise and scientific research, we offer comprehensive, personalized support that puts patients' well-being and the improvement of their care at the forefront. We are excited to continue.”
With the continuation of their collaboration, Temedica and Roche reaffirm their shared commitment to making significant strides in healthcare.
About Temedica GmbH Temedica is a health insights company based in Munich. Since 2016, Temedica has operated Europe’s leading Real-World Insights ecosystem in healthcare. Temedica's mission is to enable personalized and individualized medicine, putting patients' needs at the center. This is achieved through the linkage of health-relevant data from various sources, which are processed into valuable insights in compliance with GDPR. Temedica is supported by renowned investors with long-standing experience in the biopharmaceutical industry.
About Roche in Germany
For more information and media inquiries, please contact:
Temedica GmbH
Anna Hauner Corporate Communications E-Mail: [email protected] Tel: +49 175 4310301
Roche Pharma AG
Faten Gaber Head of Communications & Public Affairs Emil-Barell-Straße 1 79639 Grenzach-Wyhlen Tel: +49 7624 14-4000
24.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
2014625 24.10.2024 CET/CEST
- Vantage Markets cumple otro gran logro: Gana el premio al Mejor Programa de Afiliación en el Mercado de Divisas en los Global Brand Awards 2024
- Meiyume debuta en Cosmopack Asia 2024: "Elevate: Reaching New Heights in Beauty Innovation"
- Vantage Markets se une a los 20 mejores brókeres de Skyline Guide 2024: La guía Michelin de la industria de divisas
- ATR optimiza la gestión de inventario con Syncron
- Trainocate asegura la adquisición estratégica de EnterOne en Landmark TI Training Partnership
- GICSA ANUNCIA SUS RESULTADOS CONSOLIDADOS AL TERCER TRIMESTRE DE 2024